Compare RSI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSI | PRCT |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2020 | 2021 |
| Metric | RSI | PRCT |
|---|---|---|
| Price | $20.53 | $23.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $22.75 | ★ $35.44 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 05-21-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 933.33 | 1.71 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,134,428,000.00 | $308,054,000.00 |
| Revenue This Year | $25.00 | $32.85 |
| Revenue Next Year | $13.89 | $24.66 |
| P/E Ratio | $67.32 | ★ N/A |
| Revenue Growth | 22.76 | ★ 37.22 |
| 52 Week Low | $9.54 | $19.35 |
| 52 Week High | $22.65 | $64.89 |
| Indicator | RSI | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 67.10 | 35.33 |
| Support Level | $16.41 | $19.35 |
| Resistance Level | $22.55 | $29.24 |
| Average True Range (ATR) | 0.96 | 1.77 |
| MACD | 0.30 | -0.13 |
| Stochastic Oscillator | 92.17 | 41.88 |
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.